Investor Overview

Nasus Pharma is a clinical-stage biopharmaceutical company developing innovative intranasal drug delivery products. Uniquely positioned to address medical emergencies, Nasus Pharma’s Proprietary Nasax^® technology is designed to enhance intranasal drug absorption with a potential for longer drug product shelf-life via a unique powder formulation.

NYSE bell ringing interview with Dan Teleman, Nasus CEO